Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme

By sjmartinez • June 13, 2023

Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, Yamaoka K, Richez C, Palac H, Dilley D, Liu J, Strengholt S, Burmester G. Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 Jun 12:ard-2023-223916. doi: 10.1136/ard-2023-223916. Epub ahead of print. PMID: 37308218.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, methotrexate, Publications, Rheumatology, tumor necrosis factor inhibitors

Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease

Malik A, Jiang M, Muñoz G, Meymandi S, Bradfield JS, Hayase J. Resolution of ventricular tachycardia and cardiac inflammation following treatment in chronic Chagas disease.[...]

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy

Adams DH, Tang GHL, Whisenant BK, Kodali SK, Singh GD, Fam NP, Kar S, Price MJ, Spies C, Schwartz JG, Makkar RR, Tadros P, Asgar[...]

Keep Gimmicks of Toy E-Cigarettes Away and Juveniles on Track Towards the Tobacco Endgame

Zong NC, Zhang Y, Cai H. Keep Gimmicks of Toy E-Cigarettes Away and Juveniles on Track Towards the Tobacco Endgame. Chest. 2024 Dec;166(6):1293-1295. doi: 10.1016/j.chest.2024.06.3810.[...]